What are the possible findings of a Pap smear in asymptomatic females between 21 and 65 years old with no history of cervical cancer or abnormal Pap smears?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pap Smear Findings in Average-Risk Women

Normal and Abnormal Results Classification

Pap smear results in asymptomatic women aged 21-65 years are reported using the 2001 Bethesda System, which categorizes findings as normal (negative for intraepithelial lesion or malignancy), unsatisfactory, or positive for abnormalities ranging from lowest to highest risk. 1

Normal Findings

  • Negative for intraepithelial lesion or malignancy (NILM): This is the most common result, occurring in approximately 86-94% of screened women 2, 3
  • The majority of asymptomatic women will have normal cytology results, with rates varying by age 1

Unsatisfactory Results

  • Unsatisfactory for evaluation: Occurs in approximately 6% of samples and requires repeat testing 2, 3
  • Even women with HPV-negative results should have unsatisfactory tests repeated, though colposcopy is an option for women aged 30 years or older 1

Abnormal Epithelial Cell Findings (Lowest to Highest Risk)

The following abnormalities are listed in order of increasing cancer risk 1:

1. Atypical Squamous Cells of Undetermined Significance (ASC-US)

  • Most common abnormal finding, occurring in approximately 3-19% of abnormal smears 2, 3
  • Carries a predicted 5-year risk of approximately 10% for CIN grade 2 or more severe lesion when combined with positive HPV testing 1
  • Rates decrease with age: approximately 13% in women aged 21-24 years, 7% in those aged 30-34 years, and 3% in those aged 60-64 years 1

2. Low-Grade Squamous Intraepithelial Lesion (LSIL)

  • Detected in approximately 4-7.5% of abnormal smears 2, 3
  • Represents HPV-related changes and mild dysplasia 1

3. Atypical Squamous Cells - Cannot Exclude High-Grade Dysplasia (ASC-H)

  • Found in approximately 9-15% of abnormal smears 2
  • Indicates suspicion for high-grade dysplasia but not definitive 1

4. High-Grade Squamous Intraepithelial Lesion (HSIL)

  • Detected in approximately 0.5-5.5% of abnormal smears 4, 2, 3
  • Carries a predicted 5-year risk of approximately 85% for CIN grade 2 or more severe lesion 1
  • Represents moderate to severe dysplasia or carcinoma in situ 1

5. Squamous Cell Carcinoma

  • Rare finding in screening, occurring in approximately 0.5-11% of abnormal smears 2
  • Represents invasive cancer 1

6. Atypical Glandular Cells of Undetermined Significance (AGUS)

  • Detected in approximately 4-6.5% of abnormal smears 2
  • Requires further evaluation due to potential for adenocarcinoma 1

7. Adenocarcinoma

  • Rare finding, occurring in approximately 3% of abnormal smears 2
  • Represents glandular cell cancer 1

Inflammatory/Infectious Findings

  • Inflammatory smear or evidence of infection: Found in approximately 13-43% of samples 5, 4, 3
  • Does not represent precancerous or cancerous changes but indicates cervicitis or vaginitis 3

Age-Related Patterns

The prevalence of abnormal findings decreases significantly with age, reflecting the natural history of HPV infection 1:

  • Women aged 21-24 years: approximately 13% have cytologic abnormalities and 30% have positive HPV results 1
  • Women aged 30-34 years: approximately 7% have cytologic abnormalities and 12% have positive HPV results 1
  • Women aged 60-64 years: approximately 3% have cytologic abnormalities and 5% have positive HPV results 1

Clinical Context

Most women undergoing screening are asymptomatic (approximately 15-82% in various studies), though some present with vaginal discharge (37-48%), irregular menstrual cycles (11-13%), or abdominal pain (8-26%) 5, 4, 3. The underlying prevalence of CIN grade 2 or more severe lesions ranges from 12% in women aged 21-24 years to 2.4% in those older than 50 years 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical correlation of cervical cancer screening using Pap smear test.

Journal of population therapeutics and clinical pharmacology = Journal de la therapeutique des populations et de la pharmacologie clinique, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.